AIRLINK 70.75 Increased By ▲ 1.55 (2.24%)
BOP 5.04 Increased By ▲ 0.14 (2.86%)
CNERGY 4.36 Increased By ▲ 0.10 (2.35%)
DFML 31.73 Increased By ▲ 0.48 (1.54%)
DGKC 80.50 Increased By ▲ 3.25 (4.21%)
FCCL 21.15 Increased By ▲ 1.15 (5.75%)
FFBL 35.20 Increased By ▲ 0.20 (0.57%)
FFL 9.31 Increased By ▲ 0.19 (2.08%)
GGL 9.79 Decreased By ▼ -0.01 (-0.1%)
HBL 112.30 Decreased By ▼ -0.46 (-0.41%)
HUBC 135.43 Increased By ▲ 2.39 (1.8%)
HUMNL 7.05 Increased By ▲ 0.10 (1.44%)
KEL 4.34 Increased By ▲ 0.11 (2.6%)
KOSM 4.39 Increased By ▲ 0.14 (3.29%)
MLCF 37.55 Increased By ▲ 0.95 (2.6%)
OGDC 136.51 Increased By ▲ 3.64 (2.74%)
PAEL 23.63 Increased By ▲ 0.99 (4.37%)
PIAA 24.49 Increased By ▲ 0.29 (1.2%)
PIBTL 6.61 Increased By ▲ 0.15 (2.32%)
PPL 121.50 Increased By ▲ 5.20 (4.47%)
PRL 27.08 Increased By ▲ 1.18 (4.56%)
PTC 13.30 Increased By ▲ 0.22 (1.68%)
SEARL 52.40 Increased By ▲ 0.40 (0.77%)
SNGP 70.37 Increased By ▲ 2.77 (4.1%)
SSGC 10.55 Increased By ▲ 0.01 (0.09%)
TELE 8.40 Increased By ▲ 0.12 (1.45%)
TPLP 10.98 Increased By ▲ 0.18 (1.67%)
TRG 60.00 Increased By ▲ 0.71 (1.2%)
UNITY 25.10 Decreased By ▼ -0.03 (-0.12%)
WTL 1.28 Increased By ▲ 0.01 (0.79%)
BR100 7,517 Increased By 108.1 (1.46%)
BR30 24,600 Increased By 563.4 (2.34%)
KSE100 71,722 Increased By 1055.2 (1.49%)
KSE30 23,512 Increased By 288.7 (1.24%)

ISLAMABAD: The Australian High Commissioner to Pakistan, Dr Geoffrey Shaw took to twitter on Thursday to welcome COVAX initial vaccine allocation to Pakistan.

“I welcome COVAX announcement of initial vaccine allocations, including 17.2 million doses for Pakistan. Australia has contributed $80 million to COVAX.”

“We will continue to advocate for equitable access to safe and effective COVID-19 vaccines,” High Commissioner added.

Australia’s contribution to COVAX Facility’s Advance Market Commitment (AMC) will provide safe and effective vaccines to the world’s most vulnerable populations – including Pakistan.The COVAX AMC works to pool purchasing power and risk, to prepare the most diverse portfolio of COVID-19 vaccines, fast track manufacturing, and ensure developing countries are not excluded from accessing vaccines due to price constraints.—PR

Copyright Business Recorder, 2021

Comments

Comments are closed.